Table 2 Details of signaling questions in each domain of risk of bias assessment for 10 randomized controlled trials.

From: Efficacy of hypertonic dextrose injection (prolotherapy) in temporomandibular joint dysfunction: a systematic review and meta-analysis

Domains

Signaling questions

Reponses of RCTs

Refai 2011

Kilic 2016

Fouda 2018

Mustafa 2018

Louw 2018

Mahmoud 2018

Saadat 2018

Arafat 2019

Zarate 2020

Hassanien 2020

Bias arising from the randomization process

1.1 Was the allocation sequence random?

NI

NI

PY

NI

Y

NI

NI

NI

Y

NI

1.2 Was the allocation sequence concealed until participants were recruited and assigned to interventions?

NI

NI

Y

NI

Y

NI

NI

NI

Y

NI

1.3 Did baseline differences between intervention groups suggest a problem with the randomization process?

NI

N

NI

N

PY

NI

NI

NI

PN

NI

RoB judegement

SOME

SOME

LOW

SOME

SOME

SOME

SOME

SOME

LOW

SOME

Bias due to deviations from intended interventions

2.1 Were participants aware of their assigned intervention during the trial?

N

PN

PN

PN

PN

PY

PN

PY

N

PY

2.2. Were carers and people delivering the interventions aware of participants’ assigned intervention during the trial?

N

PN

PN

PN

PN

PY

PN

PY

N

PY

2.3. If Y/PY/NI to 2.1 or 2.2: Were there deviations from the intended intervention that arose because of the trial context?

NA

NA

NA

NA

NA

NI

NA

NI

NA

NI

2.4 If Y/PY to 2.3: Were these deviations likely to have affected the outcome?

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

2.5. If Y/PY/NI to 2.4: Were these deviations from intended intervention balanced between groups?

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

2.6 Was an appropriate analysis used to estimate the effect of assignment to intervention?

PY

PN

PY

N

Y

NI

PY

PY

PY

PY

2.7 If N/PN/NI to 2.6: Was there potential for a substantial impact (on the result) of the failure to analyse participants in the group to which they were randomized?

NA

PY

NA

PY

NA

NI

NA

NA

NA

NA

RoB judegement

LOW

HIGH

LOW

HIGH

LOW

HIGH

LOW

SOME

LOW

SOME

Bias due to missing outcome data

Bias in measurement of the outcome

3.1 Were data for this outcome available for all, or nearly all, participants randomized?

Y

N

PY

N

Y

NI

PY

PY

Y

PY

3.2 If N/PN/NI to 3.1: Is there evidence that the result was not biased by missing outcome data?

NA

PN

NA

PN

NA

PN

NA

NA

NA

NA

3.3 If N/PN to 3.2: Could missingness in the outcome depend on its true value?

NA

NI

NA

NI

NA

NI

NA

NA

NA

NA

3.4 If Y/PY/NI to 3.3: Is it likely that missingness in the outcome depended on its true value?

NA

PN

NA

PN

NA

PN

NA

NA

NA

NA

RoB judegement

LOW

SOME

LOW

SOME

LOW

SOME

LOW

LOW

LOW

LOW

4.1 Was the method of measuring the outcome inappropriate?

PN

PN

PN

PN

PN

PN

PN

PN

PN

PN

4.2 Could measurement or ascertainment of the outcome have differed between intervention groups?

PN

PN

PN

PN

PN

PN

PN

PN

PN

PN

4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assessors aware of the intervention received by study participants?

PN

NI

NI

NI

PN

NI

NI

NI

N

NI

4.4 If Y/PY/NI to 4.3: Could assessment of the outcome have been influenced by knowledge of intervention received?

NA

PY

PY

PY

NA

PY

PY

PY

NA

PY

4.5 If Y/PY/NI to 4.4: Is it likely that assessment of the outcome was influenced by knowledge of intervention received?

NA

PN

PN

PN

NA

PN

PN

PN

NA

PN

RoB judegement

LOW

SOME

SOME

SOME

LOW

SOME

SOME

SOME

LOW

SOME

Bias in selection of the reported result

5.1 Were the data that produced this result analysed in accordance with a pre-specified analysis plan that was finalized before unblinded outcome data were available for analysis?

NI

NI

NI

NI

PY

NI

NI

NI

NI

NI

For 5.2 and 5.3 Is the numerical result being assessed likely to have been selected, on the basis of the results, from…

5.2. … multiple eligible outcome measurements (e.g. scales, definitions, time points) within the outcome domain?

PN

PN

PY

PN

PN

PN

PN

PN

PN

PN

5.3 … multiple eligible analyses of the data?

PN

PN

PN

PN

PN

PN

PN

PN

PN

PN

RoB judegement

SOME

SOME

HIGH

SOME

LOW

SOME

SOME

SOME

SOME

SOME

Overall bias

SOME

HIGH

HIGH

HIGH

SOME

HIGH

SOME

SOME

SOME

SOME

  1. HIGH high risk of bias, LOW low risk of bias, N no, NA not applicable, NI no information, PN probably no, PY probably yes, RCTs randomized controlled trials, RoB risk of bias, SOME some concerns, Y yes.